BERWYN, PA — AscellaHealth has announced two strategic appointments to its senior leadership team, naming Clayton Edwards, RPh, MBA, as Senior Vice President of Payer Business Unit, and Carl T. Bertram, PharmD, MS, MBA, as Senior Vice President of Pharma Business Unit. These leadership enhancements are set to bolster the company’s mission of improving access to innovative therapies and optimizing clinical outcomes for individuals with rare and complex medical conditions.
Clayton Edwards brings 34 years of experience in the healthcare sector, having held influential roles at organizations such as CarelonRx Pharmacy, OptumRx, and UnitedHealthcare. Throughout his career, Edwards has been instrumental in business development, mergers, and acquisitions totaling over $19 billion, and driving $8 billion in new sales. “With 34 years of experience across various healthcare organizations, I have built a solid foundation to develop and implement AscellaHealth’s strategies for payers in both public and private sectors,” said Edwards. “I am excited to drive collaborations between payers, drug manufacturers and providers, while advancing solutions that enhance member engagement and improve the overall treatment experience.”
Carl T. Bertram offers more than 30 years of expertise in specialty pharmacy, managed care, and retail. Having held senior roles at industry giants such as Walgreens, Walmart, and CVS Health, Bertram is recognized for his innovative contributions to new healthcare models, clinical systems, and product development. “As AscellaHealth continues its impressive growth, I look forward to leveraging my extensive experience in building, leading and developing teams,” said Bertram. “Over the years, I’ve witnessed a shifting global healthcare landscape and see numerous opportunities to assist our clients in launching new therapies or expanding market share for existing products. I am excited to strengthen AscellaHealth’s strategic position, helping specialty pharmaceutical manufacturers accelerate the discovery and commercialization of life-changing therapies that improve the lives of patients with rare and complex, chronic conditions.”
Welcoming the new appointees, Bill Oldham, Chairman and President of AscellaHealth, highlighted their contributions to the company’s vision. “With their proven success in delivering results across diverse healthcare settings and driving growth in various business sectors, Clayton and Carl will be key contributors to our ongoing operational and financial success. Their deep industry knowledge and experience are directly aligned with our business model and patient-focused care approach. As critical members of our executive team, their leadership will further strengthen our position as a trusted partner within the specialty healthcare ecosystem,” Oldham stated.
The addition of Edwards and Bertram underscores AscellaHealth’s focus on cultivating partnerships among payers, providers, and pharmaceutical manufacturers. Both leaders are expected to play pivotal roles in advancing the company’s mission of delivering patient-centered solutions. These appointments signal AscellaHealth’s continued growth and its commitment to driving innovation in specialty healthcare, with a forward-looking focus on enhancing access to life-changing therapies and improving patient outcomes on a global scale.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.